Quick Answer
VitaNova Life Sciences Corp reported Total Assets of $2.26 million for the year ending 2025.
- VitaNova Life Sciences Corp showed an increase of +89.1% in Total Assets from 2024 to 2025.
- This data is from VitaNova Life Sciences Corp's annual report (Form 10-K), filed with the SEC on July 24, 2025.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $17.3 thousand | Q1 2018: $33.4 thousand | Q3 2018: $28.7 thousand | Q4 2018: $50.00 | Q1 2019: $50.00 | Q3 2019: $0.00 | Q4 2019: $0.00 | Q1 2020: $0.00 | Q3 2020: $0.00 | Q4 2020: $0.00 | Q1 2021: $0.00 | Q4 2021: $31.7 thousand | Q1 2022: $42.3 thousand | Q3 2022: $29.9 thousand | Q4 2022: $35.2 thousand | Q1 2023: $11.0 thousand | Q4 2023: $0.00 | Q1 2024: $964.4 thousand | Q3 2024: $1.20 million | Q4 2024: $1.26 million | Q1 2025: $1.32 million | Q2 2025: $2.26 million | Q3 2025: $2.24 million | Q4 2025: $2.34 million | Q1 2026: $2.31 million.
- Over the full 9 years of available data (2017 to 2025), VitaNova Life Sciences Corp's Total Assets has grown by 95,463.4%.
- Historical annual values: Fiscal year 2025: $2.26 million | Fiscal year 2024: $1.19 million | Fiscal year 2023: $8.7 thousand | Fiscal year 2022: $23.1 thousand | Fiscal year 2021: $0.00 | Fiscal year 2020: $0.00 | Fiscal year 2019: $0.00 | Fiscal year 2018: $47.8 thousand | Fiscal year 2017: $2.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: